24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-Month safety and functional outcomes

Ophthalmic Surgery Lasers and Imaging

Volumn 43, Issue 1, 2012, Pages 20-24

  Morales Canton, Virgilio ^a   Quiroz Mercado, Hugo ^a,b   Velez Montoya, Raul ^a,b   Lopez Miranda, Miriam J ^a   Moshfeghi, Andrew A ^c   Shusterman, Eugene M ^d   Kaiser, Peter K ^e   Sanislo, Steven R ^a   Gertner, Michael ^d   Moshfeghi, Darius M ^f  

^a IAP ^*

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Oraya Therapeutics Inc   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CHEMORADIOTHERAPY; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LOADING DRUG DOSE; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SAFETY; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; SINGLE DRUG DOSE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; X RAY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MIDDLE AGED; RADIOTHERAPY DOSAGE; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84856084701     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20111129-01     Document Type: Article

References (25)

1. Moshfeghi DM, Kaiser PK, Gertner M. Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol. 2010;95:185-188.
2. Lee C, Chell E, Gertner M, et al. Dosimetry characterization of a multibeam radiotherapy treatment for age-related macular degeneration. Med Phys. 2008;35:5151-5160.
3. Taddei P, Chell E, Hansen S, Gertner M, Newhauser W. Assessment of targeting accuracy of a low-energy stereotactic radiosurgery treatment for age-related macular degeneration. Phys Med Biol. 2010;55:7037-7054.
4. Hanlon J, Lee C, Chell E, et al. Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose. Med Phys. 2009;36:3671-3681.
5. Gertner M, Chell E, Pan KH, Hansen S, Kaiser PK, Moshfeghi DM. Stereotactic targeting and dose verification for age-related macular degeneration. Med Phys. 2010;37:600-606.
6. Moshfeghi AA, Canton VM, Quiroz-Mercado H, et al. 16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategy. Ophthalmic Surg Lasers Imaging. 2011;42:460-467.
7. Canton VM, Quiroz-Mercado H, Velez-Montoya R, et al. 16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomes. Ophthalmic Surg Lasers Imaging. 2011;42:468-473.
8. Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol. 2007;144:627-637.
9. Regillo CD, Brown DM, Abraham P, et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1. Am J Ophthalmol. 2008;145:239-248 e235.
10. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431. (Pubitemid 44511557)
11. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol. 1993;77:265-273. (Pubitemid 23177354)
12. Chakravarthy U, MacKenzie G. External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data. Br J Radiol. 2000;73:305-313. (Pubitemid 30192804)
13. Evans JR, Sivagnanavel V, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2010;5:CD004004.
14. Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol. 1999;127:170-177. (Pubitemid 29072557)
15. Finger PT, Berson A, Sherr D, Riley R, Balkin RA, Bosworth JL. Radiation therapy for subretinal neovascularization. Ophthalmology. 1996;103:878-889. (Pubitemid 26190720)
16. Finger PT, Gelman YP, Berson AM, Szechter A. Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study. Br J Ophthalmol. 2003;87:1497-1503. (Pubitemid 38010556)
17. Flaxel CJ, Friedrichsen EJ, Smith JO, et al. Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration. Eye. 2000;14:155-164. (Pubitemid 30265161)
18. Jaakkola A, Heikkonen J, Tarkkanen A, Immonen I. Visual function after strontium-90 plaque irradiation in patients with age-related subfoveal choroidal neovascularization. Acta Ophthalmol Scand. 1999;77:57-61. (Pubitemid 29057489)
19. Jaakkola A, Heikkonen J, Tommila P, Laatikainen L, Immonen I. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1998;236:24-30. (Pubitemid 28080567)
20. Jaakkola A, Heikkonen J, Tommila P, Laatikainen L, Immonen I. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study. Ophthalmology. 2005;112:567-573. (Pubitemid 41108854)
21. Jaakkola A, Tommila P, Laatikainen L, Immonen I. Grading choroidal neovascular membrane regression after strontium plaque radiotherapy: masked subjective evaluation vs planimetry. Eur J Ophthalmol. 2001;11:269-276. (Pubitemid 33042279)
22. Sivagnanavel V, Evans JR, Ockrim Z, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2004;(4):CD004004.
23. Zambarakji HJ, Lane AM, Ezra E, et al. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology. 2006;113:2012-2019. (Pubitemid 44635705)
24. Avila MP, Farah ME, Santos A, Duprat JP, Woodward BW, Nau J. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol. 2009;93:305-309.
25. Avila MP, Farah ME, Santos A, et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina. 2009;29:157-169.